We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+8.24%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$778M
AUM Growth
+$41.1M
Cap. Flow
-$3.71M
Cap. Flow %
-0.48%
Top 10 Hldgs %
60.4%
Holding
78
New
1
Increased
28
Reduced
40
Closed
2

Top Buys

Rank Stock Value
1
CASY icon
Casey's General Stores
CASY
+$2.7M
2
PAYC icon
Paycom
PAYC
+$1.51M
3
DHR icon
Danaher
DHR
+$1.31M
4
LLY icon
Eli Lilly
LLY
+$1.3M
5
PANW icon
Palo Alto Networks
PANW
+$1.18M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.78M
2
NVDA icon
NVIDIA
NVDA
+$4.56M
3
AAPL icon
Apple
AAPL
+$1.7M
4
PEP icon
PepsiCo
PEP
+$1.55M
5
ADBE icon
Adobe
ADBE
+$557K

Sector Composition

Rank Sector Weight
1 Technology 42.96%
2 Healthcare 15.24%
3 Consumer Discretionary 13.12%
4 Communication Services 9.2%
5 Financials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETN icon
26
Eaton
ETN
$150B
$7.77M 1%
20,782
+2,058
+11% +$749K
CRM icon
27
Salesforce
CRM
$148B
$7.24M 0.93%
30,567
-197
-0.6% -$49.7K
SBUX icon
28
Starbucks
SBUX
$121B
$6.97M 0.9%
82,042
-4,127
-5% -$369K
CNI icon
29
Canadian National Railway
CNI
$76.9B
$6.94M 0.89%
73,843
-685
-0.9% -$66.1K
RTX icon
30
RTX Corp
RTX
$289B
$6.38M 0.82%
38,180
-227
-0.6% -$35.2K
PAYX icon
31
Paychex
PAYX
$41.4B
$5.97M 0.77%
46,997
-200
-0.4% -$27.7K
NEE icon
32
NextEra Energy
NEE
$183B
$5.15M 0.66%
68,631
+385
+0.6% +$28.1K
PEP icon
33
PepsiCo
PEP
$191B
$5.05M 0.65%
36,041
-10,840
-23% -$1.55M
JPM icon
34
JPMorgan Chase
JPM
$933B
$4.95M 0.64%
15,715
-109
-0.7% -$32.4K
LLY icon
35
Eli Lilly
LLY
$1.03T
$4.56M 0.59%
5,973
+1,745
+41% +$1.3M
HD icon
36
Home Depot
HD
$332B
$4.5M 0.58%
11,124
-200
-2% -$78.6K
JNJ icon
37
Johnson & Johnson
JNJ
$617B
$4.44M 0.57%
24,007
-86
-0.4% -$14.7K
MCD icon
38
McDonald's
MCD
$191B
$2.85M 0.37%
9,374
-117
-1% -$35.6K
MNST icon
39
Monster Beverage
MNST
$95.5B
$2.82M 0.36%
42,102
+1,525
+4% +$95.2K
PG icon
40
Procter & Gamble
PG
$335B
$2.81M 0.36%
18,268
-5
-0% -$781
REGN icon
41
Regeneron Pharmaceuticals
REGN
$77.4B
$2.75M 0.35%
4,897
-8,447
-63% -$4.78M
CL icon
42
Colgate-Palmolive
CL
$73.3B
$2.33M 0.3%
29,117
-1,200
-4% -$102K
AZN icon
43
AstraZeneca
AZN
$266B
$1.94M 0.25%
12,611
+13
+0.1% +$1.97K
GNRC icon
44
Generac Holdings
GNRC
$11.3B
$1.91M 0.25%
11,420
-1,639
-13% -$287K
WMT icon
45
Walmart Inc
WMT
$884B
$1.69M 0.22%
16,397
-297
-2% -$29.6K
ABBV icon
46
AbbVie
ABBV
$455B
$1.64M 0.21%
7,071
+30
+0.4% +$6.11K
CELH icon
47
Celsius Holdings
CELH
$7.5B
$1.48M 0.19%
25,977
+1,830
+8% +$95.7K
HON icon
48
Honeywell
HON
$76.7B
$1.44M 0.19%
7,280
-44
-0.6% -$9.19K
ASML icon
49
ASML
ASML
$634B
$1.36M 0.18%
1,409
+59
+4% +$46.4K
SYY icon
50
Sysco
SYY
$40.6B
$1.22M 0.16%
14,830
-1,928
-12% -$154K

Similar funds

Dillon & Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Dillon & Associates held 78 positions worth $778M, up 5.6% from $737M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 3.8%. Dillon & Associates opened 1 new position and exited 2, leaving the 78-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 41% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Dillon & Associates's largest Q3 2025 buy was Palantir: 1,305 shares worth $238K.
  • Dillon & Associates added most to Casey's General Stores in Q3 2025, an estimated $2.7M increase.
  • Dillon & Associates's biggest Q3 2025 reduction was Regeneron Pharmaceuticals, cutting an estimated $4.78M.
  • Dillon & Associates fully exited PayPal in Q3 2025, selling an estimated $251K.
  • Dillon & Associates's ten largest holdings make up 60% of its $778M portfolio in Q3 2025.
  • Dillon & Associates opened 1 new position and closed 2 in Q3 2025.
  • Dillon & Associates's portfolio value rose 5.6% quarter-over-quarter to $778M.

Based on Dillon & Associates's 13F filing for Q3 2025, filed 28 Oct 2025.